News » Request Brochure:

WASHINGTON cheap air max sale australia , Feb. 11 (Xinhua) -- In her first testimony to the Congress, U.S. Federal Reserve Chair Janet Yellen reiterated central bank's plan to taper its stimulus exit despite recent weakness in the economy.


The current economic situation and outlook, as well as the monetary policy, were the main focus of the hearing held twice a year.


Yellen told lawmakers she expected "a great deal of continuity" in the central bank's monetary policy, saying that she served on the Fed policy-setting committee as the bank formulated its current policy strategy and she strongly supported that strategy.


Yellen, 67, took the oath of office to lead the Federal Reserve System on Feb. 3, succeeding Ben Bernanke, who stepped down after eight turbulent years. She was previously the Fed's vice Chair.


In the public debut in her new role, Yellen said while the economy gained steam at the end of 2013, recovery in the U.S. labor market was "far from complete," underscoring the importance of considering more than just the unemployment rate when evaluating the conditions of the labor market.


Her point of keeping an eye on wider range of labor indicators is particularly important as the unemployment rate, now at 6.6 percent, is near the 6.5 percent threshold the Fed once identified as the level that would need to be reached before officials would consider a hike in the interest rates.


"If coming information broadly supports the Committee's expectation of ongoing improvement in labor market conditions and inflation moving back toward its long-run objective, the Committee will likely reduce the pace of asset purchases in further measured steps at future meetings," Yellen indicated steady pullback in Fed stimulus, referring to the Federal Open Market Committee, which sets monetary policy.


While admitting she was "surprised" by the two recent jobs reports that showed the pace of job creation running under what she had expected, Yellen cautioned against jumping to conclusions of the longer trend. She told the Congress that the Fed needs to see a "notable change" in the economic outlook to consider pausing its withdrawal of stimulus.


The Fed trimmed its monthly purchases of Treasury and mortgage- backed securities by a total of 10 billion dollars in both December and January, citing strengthening economy and continued improvement in the labor market.


The Fed policymakers have suggested they would continue to reduce the bond buying, which now totals 65 billion dollars a month, at a similar pace at each Fed meeting and end it by the end of 2014, provided the economy develops generally in line with expectations.


Yellen also highlighted the Fed's financial regulatory role, saying that the work of making the financial system more robust " has not yet been completed."

EP Catheter Ablation Market to Expand at a Modest CAGR of 7.9% by 2026

by pragya1 · September 28, 2018


The healthcare sector is forever evolving and readily embraces new technologies that are proven efficient at providing cure to the community. Minimally invasive procedures have been very well received by the medical practitioners and its application has escalated in the recent past, providing a traction to the EP catheter ablation market. A recent business intelligence study by Transparency Market Research (TMR) has estimated that the聽global ET catheter ablation market聽will be worth US$2.74 bn by the end of 2026, with the demand incrementing at a formidable CAGR of 7.9% during the forecast period of 2017 to 2026.


Obtain a Detail Report:


Technological Advancements to Determine Market Leader


Owing to its apparent lucrativeness, a number of companies functioning in the healthcare industry have thrown their hat into the market for EP catheter ablation, making the value-chain-landscape fairly fragmented and intensely competitive. The report identifies Medtronic Plc., Boston Scientific Corporation, Abbott Laboratories Inc., Johnson & Johnson, BIOTRONIK SE & Co. KG, Lepu Medical Tech Co. Ltd., MicroPort Scientific Corporation, CardioFocus Inc., and Hansen Medical, Inc. as some of the key companies in the global ET catheter ablation market. Most of these companies are well established with strong geographical presence and financial might. In the near future, these companies are expected to focus on the development of advanced devices that can provide convenient diagnosis.


While Biosense Webster, which is a subsidiary of Johnson & Johnson, dominates in the cardiac ablation market as it is a major supplier of diagnostic electrophysiology catheters, and is ahead of the curve as far as localization capabilities are concerned. In the same segment, Boston Scientific is not far behind either with its Ultra ICE catheter and Blazer II RF ablation catheter products. St. Jude Medical has also expanded its outreach by acquiring Irvine Biomedical and EP Medsystems.


Request A Sample:


Over the course of the forecast period, 2017鈥?026, the analysts of the report have anticipated that the number of ablation procedures will increase as a result of approval of new diagnostic EP catheters that can incorporate localization or mapping capabilities. In addition to that, innovations pertaining to wireless and software-based diagnosis procedures are also expected carve a niche for the market players.


Request Brochure:


Based on product, the TMR report segments the EP catheter ablation market into radiofrequency (RF) ablation catheters, cryoablation electrophysiology catheters, microwave ablation (MWA) systems, navigational advanced ma. Wholesale Custom Jerseys Wholesale Authentic Jerseys Wholesale Jerseys China Cheap Wholesale College Jerseys Cheap Wholesale NFL Jerseys From China Wholesale NBA Jerseys Free Shipping Wholesale College Hockey Jerseys Cheap NBA Basketball Jerseys Wholesale College Baseball Jerseys Cheap Sports Jerseys